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Abstract Lean mass (LM) and fat mass (FM) are closely
related to bone mass (BM) in post-menopausal women,
although their relative importance is unclear. Angiogenic
factors which control angiogenesis may influence BM, LM
and FM. The aim of the study was to compare the contri-
bution of LM and FM to bone mineral density (BMD) and
the association between these tissues and circulating
angiogenic factors. The study population comprised of 392
post-menopausal women aged mean [SD] 61.8 [6.4] years.
BMD was measured at the lumbar spine (LS), neck of
femur and total hip (TH) by dual-energy X-ray absorp-
tiometry (DXA). DXA scan was also used to determine LM
and FM. Angiopoietin-1 and 2 (ANG-1, ANG-2) were
measured by sandwich enzyme-linked immunosorbent
assay. Following adjustment for confounders, significant
positive independent associations were seen between LM
with BMD at all skeletal sites (TH: p\ 0.0001) and FM
with BMD at the hip sites (TH: p = 0.004). When BMD
and LM were regressed against the angiogenic factors,
positive associations were seen between ANG-2 with LM
(p = 0.002) and LS BMD (p = 0.05). Negative associa-
tions were observed between the ratio of ANG-1/ANG-2
with LS BMD (p = 0.014), TH BMD (p = 0.049) and LM
(p = 0.029). FM and fat distribution (android/gynoid fat
ratio) were negatively associated with ANG-1 (p = 0.006)
and ANG-2 (p = 0.004), respectively. ANG-1 and ANG-2
may be involved in the maintenance of bone, muscle and
fat mass.
Keywords Bone density  Body composition  Angiogenic
factors
Introduction
Several cross-sectional studies have demonstrated signifi-
cant associations between body composition and bone mass
in post-menopausal women [1, 2]. Menopause has been
known to be associated with an increased loss of bone
mass, increased adipose mass and decreased muscle mass.
Some studies report that lean mass may be a stronger
predictor of BMD than fat mass, although the extent of the
association may be age and sex dependent [3].
The association of lean mass with bone health is evident
clinically in subjects with sarcopenia, defined as loss of
muscle as a consequence of ageing. Sarcopenia has been
linked with low bone mass, increased falls risk and frac-
tures as a result of functional decline [4]. Fat mass has been
associated with higher BMD and reduced odds ratio for
low bone mass [5]. The association seems stronger in post-
menopausal women, although the effect of fat mass may be
related to its distribution as subcutaneous fat and visceral
adipose tissue (VAT) may have differential effect on bone
[6]. In a recent study, lean mass and fat mass have been
shown to be independently associated with bone micro-
architecture, although the relationship was different. Cor-
tical area and thickness were significantly associated with
lean mass whilst trabecular number and density were
related to fat mass [7].
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Adipose tissue, skeletal muscle cells or bone cells
originate from the same pluripotent mesenchymal stem
cells and may be regulated by similar factors [8]. The
multiple cellular pathways connecting bone, skeletal mus-
cle and fat cells are complex and remain unclear. Multiple
factors are involved in the relationship between muscle and
bone. Growth hormone and insulin-like growth factor-1
(IGF-1) have been shown to have positive effects on both
and decline with ageing contributing to sarcopenia and/or
osteoporosis [9]. The association between fat and bone has
been linked to the local production of oestrogen by adipose
tissue [10]. Other factors including cytokines and
adipokines have also been implicated [11].
We hypothesise that angiogenesis or factors which reg-
ulate this process may be important in the maintenance of
muscle, fat and bone tissue. Angiopoietin-1 (ANG-1) and 2
(ANG-2) together with vascular endothelial growth factor
(VEGF) are important mediators of angiogenesis. ANG-1
and tyrosine kinase signalling are essential for regulating
blood vessel development and the stability of mature ves-
sels. ANG-2, however, works as an antagonist of ANG-1 and
works with VEGF to facilitate cell proliferation and
migration of endothelial cells. It functions as a vessel-
destabilising molecule and sensitises the endothelial cells to
the actions of exogenous cytokines or growth factors. The
balance of these 2 angiopoietins is important in the regula-
tion of angiogenesis [12]. Thus, the ratio between ANG-1
and ANG-2 is often used to investigate their effects.
It is known that angiogenesis plays an important role in
the regulation of bone remodelling and growth [13]. Pro-
angiogenic factors, such as vascular endothelial growth
factor (VEGF) and angiopoietin (ANG), are expressed at
skeletal remodelling sites supporting their role in vascular
growth throughout skeletal tissue [14, 15]. In addition to
their effect on vasculogenesis, they may also act directly on
bone cells. VEGF has been shown to regulate osteoblasts
survival and to act as a chemoattractant to osteoclasts [16].
Over-expression of ANG-1 leads to increase bone mass in
transgenic mice [17]. Their release is stimulated by bone-
derived cytokines as well as hypoxia, simulating bone
injury. It has also been proposed that sarcopenia or muscle
weakness due to ageing may be related to reduced capillary
density in the muscles [18]. Levels of various angiogenic
factors may decline in muscles with ageing. Therefore, the
release of angiogenic factors in muscles could potentially
contribute to the reversal of sarcopenia as previously sug-
gested [19, 20]. These factors may exert positive effects on
endothelial cells as well as myogenic progenitor cells
locally or at distant sites when released in the circulation.
Likewise the development and maintenance of adipose
tissue throughout adult life are also closely dependent on
the growth of a capillary network [21]. In addition, adipose
tissue can initiate the formation of blood vessel as
previously demonstrated, and in turn, endothelial cells in
adipose tissue can promote the differentiation of pre-adi-
pocyte presumably through the secretion of angiogenic
factors which act directly on pre-adipocytes in a manner
analogous to that seen in bone cells [22].
Thus, we postulate that angiogenic factors may be
associated with bone, lean and fat mass and explain, in
part, the mechanisms linking muscle, fat and bone. The aim
of this study is to explore the relationship between these
tissues and circulating angiogenic factors.
Materials and Methods
Study Population
This cross-sectional study comprised of 392 post-meno-
pausal women aged mean [SD] 61.8 [6.4] years. The
majority of participants (88.5 %) were recruited in the
osteoporosis unit following referral for a DXA scan for
measurement of their bone mineral density (BMD) or
through community advertising for study volunteers. The
rest (n = 45)were recruitedwhen they attended the unit for a
DXA scan prior to their visit to the metabolic bone clinic.
Consecutive subjects were informed about the study and
those who agreed to take part were entered in the study.
Ethical approval was obtained from the St Thomas’ Hospital
Research Ethics Committee. All participants gave informed
consent. Bone mineral density (BMD) was measured at the
lumbar spine (LS), neck of femur (FN) and total hip (TH).
DXA scan was also used to determine body composition:
lean and fat mass as well as visceral adipose tissue (VAT).
Each study participant completed a questionnaire to capture
their past and currentmedical and drug history. Fasting blood
samples (overnight fast from 10.00 pm the previous day)
were taken at the same visit and serum/plasma stored at
-80 C until analysis of the biomarkers. Exclusion criteria
were history of metabolic bone diseases other than osteo-
porosis such as Paget’s disease, chronic kidney disease–
mineral bone disorder (CKD-MBD) or vitamin D deficiency,
endocrine/biochemical abnormalities such as thyroid disor-
ders and primary hyperparathyroidism. None of the partici-
pants were on treatment with oestrogens, progestin, selective
oestrogen receptor modulators, glucocorticoids or teri-
paratide. Ninety-one subjects were on current treatment with
or had previously been on oral bisphosphonates. Participants
demographics are summarised in Table 1.
Measurement of BMD and Body Composition
by Dual-Energy X-ray Absorptiometry (DXA)
BMD was measured by DXA (Hologic QDR DXA Dis-
covery scanner, Hologic, Inc., USA) on all study
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participants at the lumbar spine (LS), femoral neck (FN)
and total hip (TH). Study participants were classified into
three groups: those with normal BMD, osteopenia and
osteoporosis according to the WHO criteria for diagnosing
osteoporosis. The CV for BMD measurement using the
spine phantom was 0.37 %.
Total lean mass (LM) and fat mass (FM) were also
measured by DXA using whole-body software version
13.4.2:3. All subjects were positioned for the scans in
accordance with manufacturer instructions. Percentage fat
mass was derived from the proportion of total tissue mass
made up of total fat mass. Quantification of fat mass in the
android and gynoid regions fat mass was carried out as
previously described [23]. The region of interest (ROI) for
the assessment of android fat was defined with the caudal
limit at the top of the iliac crest and the cephalic limit at the
base of the skull. The height of the android ROI was
automatically set to 20 % of the distance from the iliac
crest to the base of the skull. The android ROI comprises of
both VAT and subcutaneous adipose tissue (SAT). VAT is
derived by subtracting SAT from the total android fat. The
gynoid region includes the hips and upper thighs, and
overlaps both the leg and trunk regions. The upper
demarcation is below the top of the iliac crest at a distance
of 1.5 times the android height. The total height of the
gynoid region is two times the height of the android region.
The results were expressed as the android/gynoid ratio. The
CVs for the measurement of total lean and fat mass are
1 %. The VAT coefficient of variation is less than 10 %.
Routine Biochemical Measurements
Routine laboratory tests including serum creatinine and
albumin-corrected calcium were measured by standard
laboratory methods using Roche analysers (Roche Diag-
nostics Limited, West Sussex RH15 9RY, UK). Estimated
glomerular filtration rate (eGFR) was calculated using the
MDRD formula [24]. Serum intact PTH was measured
using Roche reagents on the Roche Elecsys 2010 analyser
(Roche Diagnostics Limited). Inter- and intra-assay CVs
were \5 % at mean concentrations of PTH of 41 and
105 ng/l, respectively.
Measurement of Circulating Angiogenic Factors:
VEGF, ANG-1 and ANG-2
VEGF, ANG-1 and ANG-2 concentrations were measured
in serum by sandwich enzyme-linked immunosorbent assay
(ELISA) technique (Duoset, R&D Systems Europe Ltd,
Abingdon, UK) according to the manufacturers instruc-
tions. Different ELISAs were used which were specific for
each factor. Standard curves were constructed using con-
centrations of VEGF, ANG-1 and ANG-2 ranging from
0–2, 0–10 to 0–6 ng/ml, respectively. The detection limit
of the ANG-1, ANG-2 and VEGF assays was 0.15, 0.1 and
0.02 ng/ml, respectively. Inter-assay CV was 9.4 % at
ANG-1 concentration of 45 ng/ml, 11 and 13 % at ANG-2
concentrations of 0.8 and 1.46 ng/ml, respectively. The
inter-assay CV for VEGF was 10 % at VEGF concentra-
tions of 0.26 ng/ml. The ratio of ANG-1 and ANG-2 was
derived and included in the analyses.
Statistical Analysis
Statistical analysis was performed using IBM SPSS
Statistics 20. Mean and standard deviation (SD) were
derived for all continuous variables. Multivariable linear
regression was used to examine the associations between
BMD at the LS, FN, TH with measures of body compo-
sition: LM, FM following adjustment for confounders: age,
height, smoking habits, alcohol consumption, years since
menopause, previous fractures and bisphosphonate treat-
ment. Pearson correlation or Spearman’s rank correlation
when data were non-normally distributed was used to
explore the relationship between BMD at different sites,
FM and LM with the angiogenic factors. Non-normal data
were log-transformed. In separate multilinear regression
models, the association between BMD, LM, FM, VAT, fat
distribution, android/gynoid fat ratio with the angiogenic
factors following correction for demographics and lifestyle
variables was explored. Stepwise multilinear regression
was also used to identify the strongest correlated variable.
The independent variables collectively were linearly rela-
ted to the dependent variable, as tested by plotting the
studentised residuals against the unstandardised predicted
values, and each independent variable was found to be
linearly related to the dependent variable. Group
Table 1 Summary of the demographics of the study population
Parameter Mean ± SD (%)
Number of participants 392
Age (years) 61.8 ± 6.4
Years since menopause 12.5 ± 7.6
BMI (kg/m2) 25 ± 4.5
Previous fractures (%) 128 (32.6)
Current and past smoker (%) 135 (34.4)
Bone mineral density (BMD) g/cm2
Lumbar spine (LS) 0.897 ± 0.12
Femoral neck (FN) 0.713 ± 0.104
Total hip (TH) 0.840 ± 0.109
Lean mass (kg) 40.1 ± 5.3
Fat mass (kg) 24.2 ± 8
Visceral adipose tissue (VAT) (kg) 0.43 ± 0.23
Android/gynoid ratio 0.87 ± 0.16
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comparisons were done using the unpaired Student’s ‘t’
test. A ‘p’ value of\0.05 (95 % confidence interval) was
considered as statistically significant.
Results
Study Population
Three hundred and ninety-two post-menopausal women
were studied. The study population’s demographics is
summarised in Table 1. They were divided into three
groups based on their BMD. Eighty-one women (20.7 %)
had a BMD diagnosis of osteoporosis; ‘T’ score of\-2.5
at either the LS, FN or TH, 219 (55.9 %) had osteopenia;
‘T’ score between -1 and -2.5 and 92 (23.4 %) had
normal BMD. One hundred and twenty-eight women
(32.6 %) had previously sustained a fracture. Eighty-seven
women (22 %) had previously been treated or were on oral
bisphosphonates. Lean mass (LM), fat mass (FM), % FM
and VAT in the whole study population were mean [SD]
40.15 [5.3] kg, 24.2 [8] kg, 35.7 [6.4] % and 0.43 [0.23] kg,
respectively. The circulating concentrations of the angio-
genic factors in the whole population were VEGF:
0.173[0.46] ng/ml, ANG-1: 39.9 [18.3] ng/ml, ANG-2:
0.914 [0.5] ng/ml. The concentrations of the angiogenic
factors did not differ significantly between women on BPs
compared to treatment-naı¨ve participants. LM was
significantly lower in subjects with osteoporosis compared
to those with normal BMD (p\ 0.001) or osteopenia
(p\ 0.001). There were significant differences in FM,
VAT and % fat between the three groups. Subjects with
osteoporosis had significantly lower FM (p\ 0.001) and
VAT (p = 0.001) compared to those with normal BMD.
There was no significant difference in the angiogenic fac-
tors between subjects with osteoporosis, osteopenia or
normal BMD. Data on BMD, body composition and cir-
culating angiogenic factors are summarised in Table 2.
Relationship Between Fat Mass (FM), Lean Mass
(LM) and Bone Mineral Density (BMD)
Following bivariate analyses, we observed significant
positive correlation between FM and BMD at all skeletal
sites LS (r = 0.256, p\ 0.001), FN (r = 0.332,
p\ 0.001) and TH (r = 0.360, p\ 0.001). Positive rela-
tionships were also seen between LM and BMD at all
skeletal sites LS (r = 0.372, p\ 0.001), FN (r = 0.376,
p\ 0.001) and TH (r = 0.419, p\ 0.001). A positive
correlation was seen between FM and LM (r = 0.625,
p\ 0.001). Following adjustment for confounders which
included age, height, years since menopause, previous
fractures, bisphosphonates therapy, smoking habits, alcohol
intake, in a multivariable linear regression model, signifi-
cant positive independent associations were seen between
LM with BMD at all skeletal sites. Significant associations
Table 2 Bone mineral density
(BMD), body composition and
biochemical parameters of post-
menopausal women with
normal BMD, osteopenia and
osteoporosis






Bone mineral density (g/cm2)
Lumbar spine (LS) 1.04 [0.07] 0.90 [0.09]** 0.76 [0.08]##
Femoral neck (FN) 0.84 [0.07] 0.70 [0.07]** 0.61 [0.06]##
Total hip (TH) 0.97 [0.07] 0.84 [0.08]** 0.73 [0.071]##
Body composition
Lean mass (kg) 43.3 [6.3] 39.8 [4.3]** 37.5 [3.9]##
Fat mass (kg) 27.9 [9.5] 23.9 [7.0]** 21 [6.7]##
Visceral adipose tissue (VAT) (g) 493 [251] 422 [222]* 375 [216]##
Android/gynoid ratio 0.91 [0.14] 0.86 [0.16]* 0.82 [0.17]##
Biochemical parameters
eGFR (ml/min) 78.9 [13.5] 79.9 [15] 79.2 [15]
Parathyroid hormone (PTH) (ng/l) 38.4 [12.2] 39 [11.5] 39.9 [10.6]
Serum albumin-corrected calcium (mmol/l) 2.38 [0.07] 2.37 [0.10] 2.36 [0.08]
Angiogenic factors
Vascular endothelial growth factor (VEGF) (ng/ml) 0.141 [0.18] 0.17 [0.42] 0.213 [0.73]
Angiopoietin-1 (ANG-1) (ng/ml) 39.2 [19.5] 40.2 [17.7] 40 [19]
Angiopoietin-2 (ANG-2) (ng/ml) 0.95 [0.47] 0.91 [0.53] 0.89 [0.44]
ANG-1/ANG-2 ratio 46.9 [26.4] 54.9 [52] 50 [22.5]
* p\ 0.05; ** p\ 0.01 normal BMD v/s osteopenia, # p\ 0.05; ## p\ 0.01 normal BMD v/s
osteoporosis
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were seen between FM and BMD at the TH and FN only
(Table 3). Using stepwise linear regression, LM was the
strongest predictor of BMD at the LS, TH, FN
(p\ 0.0001) for each model composed of different sets of
variables including FM.
Relationship Between BMD and the Angiogenic
Factors: VEGF, ANG-1, ANG-2 and ANG-1/ANG-2
Ratio
BMD at the LS, FN, TH and WB was regressed against the
angiogenic factors and ANG-1/ANG-2 ratio individually
and adjusted for co-variates including age, years since
menopause, smoking habits, alcohol intake, BMI, bispho-
sphonates use and biochemical variables, eGFR and PTH
concentrations. A positive association was seen between
LS BMD and ANG-2 (p = 0.055). Significant negative
associations were observed between the ratio of ANG-1/
ANG-2 with LS BMD (p = 0.014) and TH BMD
(p = 0.049). No significant associations were observed
between BMD at any site with VEGF (Table 4). Stepwise
linear regression showed that, amongst the angiogenic
factors, ANG-2 was the strongest predictor of LS BMD
(p = 0.009) in a model which consisted of age, BMI, use
of bisphosphonates, ANG-1 and ANG-2.
Relationship Between Lean Mass (LM)
and the Angiogenic Factors: VEGF, ANG-1, ANG-2
and ANG-1/ANG-2 Ratio
There was a significant positive correlation between LM
and ANG-2 (r = 0.12, p = 0.008) and a negative corre-
lation with ANG-1/ANG-2 ratio (r = -0.11, p = 0.037).
When LM was regressed against the angiogenic factors
following adjustment for the demographics and lifestyle
co-variates, the association with ANG-2 (p = 0.002) and
ANG-1/ANG-2 ratio (p = 0.029) remained significant. We
did not observe any significant association between LM
and ANG-1 or VEGF (Table 5). Stepwise linear regression
showed that ANG-2 was the strongest predictor of LM in a
model which consisted of BMI and years since menopause
(YSM) as variables.
Relationship Between Fat Mass (FM), VAT, % Body
Fat and the Angiogenic Factors: VEGF, ANG-1,
ANG-2 and ANG-1/ANG-2 Ratio
There were no significant correlation between total body
FM and the angiogenic factors (ANG-1: p = 0.11, ANG-2:
p = 0.17, VEGF: p = 0.25) following bivariate analyses.
In contrast, we observed a significant positive correlation
Table 3 Linear regression analysis of bone mineral density (BMD)
(g/cm2) as dependent variable with body composition: lean mass and
fat mass (kg) following correction for covariates including age, years
since menopause, height, fracture history, smoking habits, alcohol
intake, bisphosphonate therapy
Total hip (TH) Femoral neck (FN) Lumbar spine (LS)
Beta B
CI (95 %)
p value Beta B
CI (95 %)
p value Beta B
CI (95 %)
p value
Dependent variable: bone mineral density (g/cm2)
Fat mass (kg) 0.158 0.001, 0.004 0.004 0.169 0.001, 0.004 0.004 0.062 -0.001, 0.003 0.312
Lean mass (kg) 0.313 0.004, 0.009 0.000 0.221 0.002, 0.007 0.001 0.286 0.003, 0.010 0.000
The label for standardised co-efficient is beta, and B refers to the unstandardised co-efficient. Significant variables are shown in bold
Table 4 Linear regression analysis of bone mineral density (BMD)
as dependent variable with the angiogenic factors and ANG-1/ANG-2
ratio following correction for covariates including age, years since
menopause, BMI, smoking habits, alcohol intake, bisphosphonate
therapy, eGFR and PTH
Total hip (TH) Femoral neck (FN) Lumbar spine (LS)
Beta B
CI (95 %)
p value Beta B
CI (95 %)




Bone mineral density (g/cm2)
VEGF (ng/ml) 0.000 -0.020, 0.021 0.996 -0.015 -0.024, 0.017 0.745 -0.035 -0.034, 0.016 0.478
ANG-1 (ng/ml) -0.048 -0.001, 0.000 0.297 -0.042 -0.001, 0.000 0.373 -0.080 -0.001, 0.000 0.102
ANG-2 (ng/ml) 0.046 -0.009, 0.029 0.305 0.001 -0.019, 0.019 0.978 0.093 20.001, 0.046 0.055
ANG-1/ANG-2 ratio 20.089 20.001, 0.000 0.049 -0.028 0.000, 0.000 0.547 20.120 20.001, 0.000 0.014
The label for standardised co-efficient is beta, and B refers to the unstandardised co-efficient. Significant variables are shown in bold
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between VAT and VEGF (r = 0.11, p = 0.03) and a
negative correlation between % body fat and ANG-2
(r = -0.116, p = 0.024). In multilinear regression analy-
ses, there were negative associations between FM with
ANG-1 (p = 0.004) and with ANG-2 (p = 0.046),
although the association seemed closer with ANG-1. Sta-
tistically significant negative associations were shown
between fat percentage and both ANG-1 (r = -0.108,
p = 0.039) and ANG-2 (r = -0.184, p = 0.000). There
were no significant associations following adjustment
between VAT and the angiogenic factors. A significant
negative association was observed between the android/
gynoid ratio with ANG-2 (p = 0.004) (Table 5). Stepwise
linear regression showed that ANG-1 was the strongest
predictor of FM in a model (p = 0.005) which consisted of
BMI as variable. Amongst the angiogenic factors, ANG-2
was the strongest predictor of the android/gynoid ratio in a
model (p = 0.004) which also consisted of BMI.
Discussion
In summary, our data show that although both LM and FM
were positively associated with BMD in post-menopausal
women, the relationship with LM was closer at all skeletal
sites. Significant but contrasting associations were
observed between ANG-1, ANG-2 and their ratio with
BMD, LM and FM suggesting that these angiogenic factors
may have a role in the regulation of bone mass and body
composition.
The findings of the current study confirm the importance
of LM and FM as determinants of BMD as previously
described [1, 2]. Stronger positive associations have been
reported between LM and BMD compared to FM in men
and pre-menopausal women [25, 26]. In post-menopausal
women, the effect of FM and LM on BMD has been shown
to be similar [27]. This is in contrast to our findings as we
showed that LM had a closer relationship with BMD
compared to FM. Our data are in accordance with a pre-
vious study in a cohort of post-menopausal Vietnamese
women [28]. Several hypotheses have been proposed to
explain the significant association between body compo-
sition and BMD including the effects of endocrine, auto-
crine/paracrine and lifestyle factors including nutrition and
physical activity [7]. We hypothesised that similar factors
or mechanistic pathways may influence the metabolism of
these tissues.
We thus investigated the role of angiogenic factors and
their association with BMD, LM and FM. We observed an
independent positive association between ANG-2 and
BMD at the LS and negative associations between ANG-1/
ANG-2 ratio with BMD at the LS and TH. Angiogenesis
plays a key role in bone repair and remodelling on the
endosteal surfaces of trabecular bone or the haversian
system within cortical bone [13]. Bone remodelling not
only involves bone resorption and formation but also a
coupling with angiogenesis. ANG-1 and ANG-2 have
opposing effects on the endothelial-specific receptor tyr-
osine kinase 2 (TIE2). ANG-1 stimulates TIE2 whilst
ANG-2 is capable of antagonising this [12]. Thus, sig-
nalling through TIE2 depends on the balance between
ANG-1 and ANG-2. The balance of these 2 factors in
favour of ANG-2, as shown in our study, appears to indi-
cate that new vessel formation may be associated with bone
mass. Indeed, studies have shown a reduction in the
number of capillaries density in histological samples of
osteoporotic bones [29].
We also demonstrated similar associations between
ANG-2 and ANG-1/ANG-2 ratio with LM. Our observa-
tions suggest that skeletal muscle capillarisation may play a
role in the maintenance of muscle mass and a reduction in
angiogenesis may contribute to sarcopenia and physical
decline in elderly people [18]. Indeed, animal studies have
shown that endothelial cell apoptosis and impairment in
capillary function leads to a decline in muscle mass [30]. On
the other hand, capillary proliferation results in
Table 5 Linear regression analysis of body composition and android/
gynoid ratio as dependent variable with the angiogenic factors and
ANG-1/ANG-2 ratio following correction for covariates including
age, years since menopause, BMI, smoking habits, alcohol intake,
bisphosphonate therapy, eGFR and PTH
Lean mass (kg) Fat mass (kg) Android/gynoid ratio
Beta B
CI (95 %)
p value Beta B
CI (95 %)




VEGF (ng/ml) 0.014 -0.737, 1.05 0.731 -0.005 -0.881, 0.708 0.831 0.063 -0.008, 0.050 0.153
ANG-1 (ng/ml) 0.004 -0.021, 0.024 0.922 20.064 20.048, 20.008 0.006 -0.015 -0.001, 0.001 0.741
ANG-2 (ng/ml) 0.122 0.471, 2.077 0.002 -0.043 -1.409, 0.035 0.062 20.123 20.065, 20.012 0.005
ANG-1/ANG-2 ratio 20.107 20.036, 20.006 0.007 0.007 -0.011, 0.016 0.762 0.036 0.000, 0.001 0.412
Significant variables are shown in bold. The label for standardised co-efficient is beta, and B refers to the unstandardised co-efficient
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improvement in muscle mass by presumably allowing
oxygen and nutrient delivery to the muscle cells [20]. It has
also been shown that aerobic exercise training can increase
muscle capillarisation [31], although the effect of exercise
on ANG-1 and ANG-2 is not known. All participants in the
current study were ambulant; however, we do not have an
accurate measure of their level of physical activity. Never-
theless, our findings, albeit cross-sectional in nature, are of
interest although further confirmatory studies are required.
Adipose tissue is unique in its plasticity and undergoes
expansion and regression throughout adult life [22]. The
growth of adipose tissue requires the formation of a cap-
illary network. It is associated with angiogenesis in a
context-dependent manner [21]. Animal studies have
shown that ANG-1 mRNA expression is downregulated in
obesity and with weight change [32, 33]. ANG-1 expres-
sion is negatively related to adipose tissue weight [35],
suggesting that ANG-1 may negatively affect adipose tis-
sue growth and thus explaining, in part, the observed
negative association between ANG-1 and FM in this study.
Several other angiogenic factors including ANG-2 and the
angiogenesis inhibitor endostatin are significantly elevated
in either overweight or obese subjects compared to lean
individuals [34]. It is thought, though as yet unproven, that
adipose tissue itself may contribute to the elevated circu-
lating levels of these factors. This was not, however, seen
in our study. An explanation is that the expression of ANG-
2 may depend on the anatomical distribution of fat tissue.
A negative association between the android/gynoid ratio
and circulating ANG-2 levels was observed, therefore
suggesting higher ANG-2 to be associated with an android/
gynoid ratio favouring a gynoid fat distribution. To our
knowledge, there are no previous data showing such an
association and this remains to be elucidated. Not only FM
but fat distribution has been shown to contribute to bone
strength in post-menopausal women. Indeed, a negative
association between android/gynoid ratio and hip bone
strength has previously been documented [35].
A major strength of the study is that we have carefully
screened participants who are ambulant community-
dwelling women in good health with no clinical evidence
of cardiovascular disease or kidney disease. Another
strength is that the cohort is well characterised which
enabled us to adjust for confounders or covariates. How-
ever, there are some limitations to the study which should
be taken into account when interpreting the findings.
Firstly, because of the cross-sectional design of the study,
we are not able to determine any causal relationship
between the angiogenic factors with BMD, LM and FM.
Another limitation is that we have assumed that circulating
concentrations of these angiogenic factors reflect the local
tissue concentrations. Although the participants did not
have clinical cardiovascular disease at study entry, we are
not able to exclude sub-clinical ischaemic disease which
could affect the production and secretion of the angiogenic
factors. Recruitment of some participants from the meta-
bolic bone clinic may have introduced bias, although the
number was relatively small. Finally, although all partici-
pants were reported as being ambulant, we did not have an
accurate objective assessment of their physical activity
level, a potential confounder, which can explain the asso-
ciation between BMD and LM. We did not also analyse
other mediators which include oestradiol, cytokines,
adipokines or growth factors such as IGF-1 or sclerostin
[36] which may play a key role in the relationship between
body composition and BMD. Sclerostin has been shown to
be positively correlated with BMD and FM. In addition, we
did not capture dietary or nutritional intake which is
associated with bone health, FM as well as LM.
In conclusion, we have shown that ANG-1, ANG-2 and
ANG-1/ANG-2 ratio display significant associations with
components of body composition and bone mass. The
differing associations identified with FM compared to LM
and BMD may reflect the differential regulation of the
angiopoietins by factors produced by adipose tissue such as
adipokines. Our data therefore suggest that ANG-1 and
ANG-2 may affect bone, muscle and fat mass. Longitudi-
nal studies are required to establish a deeper understanding
and causal relationship between bone, LM, FM and the
angiogenic factors.
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